文献速递糖尿病肥胖与代谢综合征

1988-2015年美国糖尿病人群与非糖尿病人群癌症死亡率趋势

Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015.
PubMed 文献 · Diabetologia · 2019-09-12

该研究基于1985-2012年美国国家健康访谈调查数据,链接国家死亡指数追踪至2015年,比较自我报告诊断糖尿病的成人与非糖尿病成人的特定部位癌症死亡率。研究发现两组癌症死亡率均下降约25%,但糖尿病人群始终比非糖尿病人群高约30%,且部分亚组(黑人、低教育水平、肥胖者)死亡率未下降,肥胖糖尿病人群超额风险增加。

要点

  • 糖尿病人群癌症死亡率从39.1降至29.7/万人年,降幅25.5%,趋势P<0.001。
  • 非糖尿病人群从30.9降至23.2/万人年,降幅25.2%,趋势P<0.01。
  • 糖尿病人群癌症死亡风险始终高约30%,该超额风险未随时间改善。

核心结论

  • 糖尿病与非糖尿病人群癌症死亡率均下降,但糖尿病人群仍高约30%且超额风险未改善。
  • 黑人、低教育水平和肥胖的糖尿病人群癌症死亡率未下降,肥胖者超额风险增加。

研究设计与样本

  • 研究纳入1985-2012年国家健康访谈调查中≥18岁成人,链接国家死亡指数追踪至2015年底。
  • 采用离散泊松回归模型估计五个时间段的癌症死亡率,调整年龄、性别和种族/族裔。

主要发现

  • 糖尿病人群年龄调整癌症死亡率从1988-1994年的39.1(95%CI 30.1, 50.8)降至2010-2015年的29.7(26.6, 33.1),下降25.5%,ptrend<0.001。
  • 非糖尿病人群从30.9(28.6, 33.4)降至23.2(22.1, 24.2),下降25.2%,ptrend<0.01。
  • 糖尿病人群中胰腺癌死亡率相对下降55%,乳腺癌下降65%,肺癌仅下降7%。
  • 黑人、低教育水平和肥胖的糖尿病人群癌症死亡率未下降,肥胖者超额风险增加。

临床怎么用

  • 对糖尿病人群应持续加强癌症风险因素控制,尤其关注黑人、低教育水平和肥胖亚组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Cancer-related death is higher among people with vs without diabetes. However, it is not known if this excess risk has changed over time or what types of cancer may be driving these changes. METHODS: To estimate rates of site-specific cancer mortality in adults with vs without self-reported diagnosed diabetes, we used data from adults aged ≥18 years at the time of the interview who participated in the 1985-2012 National Health Interview Survey. Participants' data were linked to the National Death Index by the National Center for Health Statistics to determine vital status and cause of death through to the end of 2015. Cancer deaths were classified according to underlying cause of death. Death rates for five time periods (1988-1994, 1995-1999, 2000-2004, 2005-2009, 2010-2015) were estimated using discrete Poisson regression models adjusted for age, sex and race/ethnicity with p for linear trend reported (ptrend). Site-specific cancer mortality rates were stratified by diabetes status and period, and total cancer mortality rates were additionally stratified by sex, race/ethnicity, education and BMI status. RESULTS: Among adults with diabetes, age-adjusted cancer mortality rates (per 10,000 person-years) declined 25.5% from 39.1 (95% CI 30.1, 50.8) in 1988-1994 to 29.7 (26.6, 33.1) in 2010-2015, ptrend < 0.001. Among adults without diabetes, rates declined 25.2% from 30.9 (28.6, 33.4) in 1988-1994 to 23.2 (22.1, 24.2) in 2010-2015, ptrend < 0.01. Adults with diabetes remained approximately 30% more likely to die from cancer than people without diabetes, and this excess risk did not improve over time. In adults with diabetes, cancer mortality rates did not decline in some population subgroups (including black people, people with lower levels of education and obese people), and the excess risk increased for obese adults with vs without diabetes. Declines in total cancer mortality rates in adults with diabetes appear to be driven by large relative declines in cancers of the pancreas (55%) and breast (65%), while for lung cancer, declines are modest (7%). CONCLUSIONS/INTERPRETATION: Declines in cancer mortality rates were observed in adults with and without diabetes. However, adults with diabetes continue to be more likely to die from cancer than people without diabetes. This study highlights the continued need for greater cancer risk-factor mitigation, especially in adults with diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Harding JL, Andes LJ, Gregg EW, et al. Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015. Diabetologia. 2019. PMID: 31511931. doi:10.1007/s00125-019-04991-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。